Zwitterionic Polymer: A New Paradigm for Protein Conjugation beyond PEG

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Protein Engineering

Background:

• Polyethylene glycol (PEG)ylation enhances protein drug stability, circulation time, and reduces immunogenicity.
• However, PEG's non-degradability and potential for anti-PEG antibodies raise concerns about chronic toxicity and long-term efficacy.
• Existing PEGylated protein drugs face limitations requiring novel conjugation strategies.

Purpose of the Study:

• To explore zwitterionic polymers as a superior alternative to PEG for protein drug conjugation.
• To discuss the unique properties and advantages of protein-zwitterionic polymer conjugates.
• To present future research directions for zwitterionic polymer-based protein therapeutics.

Main Methods:

• Conceptual review of existing literature on PEGylation and zwitterionic polymers.
• Analysis of the structural and hydration properties of zwitterionic polymers compared to PEG.
• Discussion of the potential benefits of protein-zwitterionic polymer conjugates.

Main Results:

• Zwitterionic polymers exhibit distinct hydration behaviors compared to PEG.
• Protein-zwitterionic polymer conjugates demonstrate potential advantages over PEGylated proteins.
• These advantages include improved stability, reduced immunogenicity, and potential biodegradability.

Conclusions:

• Zwitterionic polymers represent a promising next-generation alternative to PEG for protein drug modification.
• Protein-zwitterionic polymer conjugates may overcome key limitations of current PEGylated biologics.
• Further research is warranted to fully realize the therapeutic potential of these novel conjugates.